Literature DB >> 3300368

Angiotensin receptor subtypes of the kidney cortex.

J G Douglas.   

Abstract

Angiotensin II (ANG II) binds with high affinity to specific renal receptors and exerts major influences on hemodynamics and tubular transport. Glomerular and tubular epithelial receptors are well characterized in contrast to pre- and postglomerular and medullary vasculature. Therefore, the scope of this review is limited to an indepth comparison of ANG II receptor kinetics, analogue specificity, and mechanisms of receptor regulation and signal transduction in glomeruli and epithelial cells. Despite the fact that these receptors are in close proximity anatomically, there is evidence from a number of laboratories that permits classification into two distinct receptor subtypes. The receptor of the glomerular mesangium, classified herein as "type A," is characterized by high affinity for ANG II and the heptapeptide, des-Asp1-Ang II (ANG III), "downregulation" with high ambient concentrations of ANG II and signal transduction mediated by phospholipase C-induced Ca2+ transients. The tubular epithelial ANG II receptor, "type B," is of lower affinity for ANG II and ANG III, "upregulated" by high levels of ANG II and mediates inhibition of adenylate cyclase following coupling to an inhibitory GTP binding protein. Both receptors possess secondary mechanisms of signal transduction that may also participate in regulation of cellular function(s). These findings support the hypothesis that at least two distinct classes of ANG II receptors are present in the kidney cortex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300368     DOI: 10.1152/ajprenal.1987.253.1.F1

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  41 in total

1.  Effect of luminal angiotensin II receptor antagonists on proximal tubule transport.

Authors:  A Quan; M Baum
Journal:  Am J Hypertens       Date:  1999-05       Impact factor: 2.689

Review 2.  Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.

Authors:  Brianne Ellis; Xiao C Li; Elisa Miguel-Qin; Victor Gu; Jia L Zhuo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 3.  Should we aim at tissue renin-angiotensin systems?

Authors:  J F Smits; R C Passier; M J Daemen
Journal:  Pharm World Sci       Date:  1998-06

Review 4.  Peptide-dependent regulation of epithelial nephron functions.

Authors:  M Horster; M Sone
Journal:  Klin Wochenschr       Date:  1989-09-01

5.  Relationship between phospholipase C activation and prostaglandin E2 and cyclic adenosine monophosphate production in rabbit tubular epithelial cells. Effects of angiotensin, bradykinin, and arginine vasopressin.

Authors:  C Welsh; G Dubyak; J G Douglas
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.

Authors:  K L Clark; M J Robertson; G M Drew
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

7.  Renin expression in renal proximal tubule.

Authors:  O W Moe; K Ujiie; R A Star; R T Miller; J Widell; R J Alpern; W L Henrich
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Cytoskeleton-dependent endocytosis is required for apical type 1 angiotensin II receptor-mediated phospholipase C activation in cultured rat proximal tubule cells.

Authors:  J R Schelling; A S Hanson; R Marzec; S L Linas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

9.  Cyclic adenosine monophosphate acutely inhibits and chronically stimulates Na/H antiporter in OKP cells.

Authors:  A Cano; P Preisig; R J Alpern
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  Expression of AT2 receptors in the developing rat fetus.

Authors:  E F Grady; L A Sechi; C A Griffin; M Schambelan; J E Kalinyak
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.